We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
- Authors
Mehta, Atul
- Abstract
The author reflects on the results of a study by H. Ben Turkia and colleagues on the treatment of type 1 Gaucher's disease with velaglucerase alfa or imiglucerase in enzyme replacement therapy. He discusses how the study was conducted which involved a comparison of the safety and efficacy of velaglucerase alfa and imiglucerase for nine months. The results reportedly revealed that velaglucerase is less immunogenic compared with imiglucerase.
- Subjects
GAUCHER'S disease treatment; ENZYME regulation; TURKIA, H. Ben; CLINICAL trials; IMMUNOGENETICS; IMMUNOLOGY
- Publication
Current Medical Literature: Lysosomal Storage Disease, 2013, Vol 11, Issue 3, p80
- ISSN
1473-0901
- Publication type
Opinion